APO Research
Talk to an analyst

APO RESEARCH · REPORT

B2B2C Health Insurance

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global B2B2C Health Insurance Market Outlook and Growth Opportunities 2026

5 March 2026192 pages

Choose your research edition.

Industry ResearchB2B2C Health Insurance Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal B2B2C Health Insurance Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal B2B2C Health Insurance Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal B2B2C Health Insurance Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal B2B2C Health Insurance Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global B2B2C Health Insurance market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for B2B2C Health Insurance is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for B2B2C Health Insurance is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for B2B2C Health Insurance is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the B2B2C Health Insurance market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the B2B2C Health Insurance market include Aditya Birla General Insurance, AXA SA, Allianz SE, Assicurazioni Generali, Berkshire Hathaway, ICICI Lombard, Prudential, UnitedHealth Group and BNP Paribas, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global B2B2C Health Insurance market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of B2B2C Health Insurance and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents B2B2C Health Insurance revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global B2B2C Health Insurance market.

B2B2C Health Insurance Segment by Company

Aditya Birla General Insurance

AXA SA

Allianz SE

Assicurazioni Generali

Berkshire Hathaway

ICICI Lombard

Prudential

UnitedHealth Group

BNP Paribas

Edelweiss General Insurance Company

Tata-AIG General Insurance

B2B2C Health Insurance Segment by Type

Critical Illness Insurance

Accident Medical Insurance

Disease Management Insurance

Other

B2B2C Health Insurance Segment by Application

Individuals

Corporates

B2B2C Health Insurance Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global B2B2C Health Insurance status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the B2B2C Health Insurance key companies, revenue, market share, and recent developments.

3. To split the B2B2C Health Insurance breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions B2B2C Health Insurance market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify B2B2C Health Insurance significant trends, drivers, influence factors in global and regions.

6. To analyze B2B2C Health Insurance competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global B2B2C Health Insurance market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of B2B2C Health Insurance and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of B2B2C Health Insurance.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global B2B2C Health Insurance industry.

Chapter 3: Detailed analysis of B2B2C Health Insurance company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of B2B2C Health Insurance in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of B2B2C Health Insurance in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. B2B2C Health Insurance Industry Trends Table 2. B2B2C Health Insurance Industry Drivers Table 3. B2B2C Health Insurance Industry Opportunities and Challenges Table 4. B2B2C Health Insurance Industry Restraints Table 5. Global B2B2C Health Insurance Revenue by Company (US$ Million) & (2021-2026) Table 6. Global B2B2C Health Insurance Revenue Share by Company (2021-2026) Table 7. Global B2B2C Health Insurance Company Ranking, (2024-2026) & (US$ Million) Table 8. Global B2B2C Health Insurance Key Company Manufacturing Base & Headquarters Table 9. Global B2B2C Health Insurance Company, Product Type & Application Table 10. Global B2B2C Health Insurance Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global B2B2C Health Insurance by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Critical Illness Insurance Table 15. Significant Companies of Accident Medical Insurance Table 16. Significant Companies of Disease Management Insurance Table 17. Significant Companies of Other Table 18. Global B2B2C Health Insurance Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global B2B2C Health Insurance Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global B2B2C Health Insurance Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global B2B2C Health Insurance Sales Value Share by Type (2021-2026) Table 22. Global B2B2C Health Insurance Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Individuals Table 24. Significant Companies of Corporates Table 25. Global B2B2C Health Insurance Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global B2B2C Health Insurance Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global B2B2C Health Insurance Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global B2B2C Health Insurance Sales Value Share by Application (2021-2026) Table 29. Global B2B2C Health Insurance Sales Value Share by Application (2027-2032) Table 30. Global B2B2C Health Insurance Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global B2B2C Health Insurance Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global B2B2C Health Insurance Sales Value Share by Region (2021-2026) Table 33. Global B2B2C Health Insurance Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global B2B2C Health Insurance Sales Value Share by Region (2027-2032) Table 35. Global B2B2C Health Insurance Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global B2B2C Health Insurance Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global B2B2C Health Insurance Sales Value Market Share by Country (2021-2026) Table 38. Global B2B2C Health Insurance Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global B2B2C Health Insurance Sales Value Market Share by Country (2027-2032) Table 40. Aditya Birla General Insurance Company Information Table 41. Aditya Birla General Insurance Business Overview Table 42. Aditya Birla General Insurance B2B2C Health Insurance Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Aditya Birla General Insurance B2B2C Health Insurance Product Portfolio Table 44. Aditya Birla General Insurance Recent Development Table 45. AXA SA Company Information Table 46. AXA SA Business Overview Table 47. AXA SA B2B2C Health Insurance Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. AXA SA B2B2C Health Insurance Product Portfolio Table 49. AXA SA Recent Development Table 50. Allianz SE Company Information Table 51. Allianz SE Business Overview Table 52. Allianz SE B2B2C Health Insurance Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Allianz SE B2B2C Health Insurance Product Portfolio Table 54. Allianz SE Recent Development Table 55. Assicurazioni Generali Company Information Table 56. Assicurazioni Generali Business Overview Table 57. Assicurazioni Generali B2B2C Health Insurance Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Assicurazioni Generali B2B2C Health Insurance Product Portfolio Table 59. Assicurazioni Generali Recent Development Table 60. Berkshire Hathaway Company Information Table 61. Berkshire Hathaway Business Overview Table 62. Berkshire Hathaway B2B2C Health Insurance Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Berkshire Hathaway B2B2C Health Insurance Product Portfolio Table 64. Berkshire Hathaway Recent Development Table 65. ICICI Lombard Company Information Table 66. ICICI Lombard Business Overview Table 67. ICICI Lombard B2B2C Health Insurance Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. ICICI Lombard B2B2C Health Insurance Product Portfolio Table 69. ICICI Lombard Recent Development Table 70. Prudential Company Information Table 71. Prudential Business Overview Table 72. Prudential B2B2C Health Insurance Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Prudential B2B2C Health Insurance Product Portfolio Table 74. Prudential Recent Development Table 75. UnitedHealth Group Company Information Table 76. UnitedHealth Group Business Overview Table 77. UnitedHealth Group B2B2C Health Insurance Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. UnitedHealth Group B2B2C Health Insurance Product Portfolio Table 79. UnitedHealth Group Recent Development Table 80. BNP Paribas Company Information Table 81. BNP Paribas Business Overview Table 82. BNP Paribas B2B2C Health Insurance Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. BNP Paribas B2B2C Health Insurance Product Portfolio Table 84. BNP Paribas Recent Development Table 85. Edelweiss General Insurance Company Company Information Table 86. Edelweiss General Insurance Company Business Overview Table 87. Edelweiss General Insurance Company B2B2C Health Insurance Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Edelweiss General Insurance Company B2B2C Health Insurance Product Portfolio Table 89. Edelweiss General Insurance Company Recent Development Table 90. Tata-AIG General Insurance Company Information Table 91. Tata-AIG General Insurance Business Overview Table 92. Tata-AIG General Insurance B2B2C Health Insurance Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. Tata-AIG General Insurance B2B2C Health Insurance Product Portfolio Table 94. Tata-AIG General Insurance Recent Development Table 95. Research Programs/Design for This Report Table 96. Authors List of This Report Table 97. Secondary Sources Table 98. Primary Sources List of Figures Figure 1. B2B2C Health Insurance Product Image Figure 2. Global B2B2C Health Insurance Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global B2B2C Health Insurance Market Size (2021-2032) & (US$ Million) Figure 4. Global B2B2C Health Insurance Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Critical Illness Insurance Image Figure 8. Accident Medical Insurance Image Figure 9. Disease Management Insurance Image Figure 10. Other Image Figure 11. Global B2B2C Health Insurance Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global B2B2C Health Insurance Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global B2B2C Health Insurance Sales Value Share by Type (2021-2032) Figure 14. Individuals Image Figure 15. Corporates Image Figure 16. Global B2B2C Health Insurance Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global B2B2C Health Insurance Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global B2B2C Health Insurance Sales Value Share by Application (2021-2032) Figure 19. Global B2B2C Health Insurance Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global B2B2C Health Insurance Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America B2B2C Health Insurance Sales Value (2021-2032) & (US$ Million) Figure 22. North America B2B2C Health Insurance Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe B2B2C Health Insurance Sales Value (2021-2032) & (US$ Million) Figure 24. Europe B2B2C Health Insurance Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific B2B2C Health Insurance Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific B2B2C Health Insurance Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America B2B2C Health Insurance Sales Value (2021-2032) & (US$ Million) Figure 28. South America B2B2C Health Insurance Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa B2B2C Health Insurance Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa B2B2C Health Insurance Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA B2B2C Health Insurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA B2B2C Health Insurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA B2B2C Health Insurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada B2B2C Health Insurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada B2B2C Health Insurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada B2B2C Health Insurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico B2B2C Health Insurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico B2B2C Health Insurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico B2B2C Health Insurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany B2B2C Health Insurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany B2B2C Health Insurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany B2B2C Health Insurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France B2B2C Health Insurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France B2B2C Health Insurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France B2B2C Health Insurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. B2B2C Health Insurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. B2B2C Health Insurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. B2B2C Health Insurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy B2B2C Health Insurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy B2B2C Health Insurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy B2B2C Health Insurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain B2B2C Health Insurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain B2B2C Health Insurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain B2B2C Health Insurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia B2B2C Health Insurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia B2B2C Health Insurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia B2B2C Health Insurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands B2B2C Health Insurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands B2B2C Health Insurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands B2B2C Health Insurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries B2B2C Health Insurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries B2B2C Health Insurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries B2B2C Health Insurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China B2B2C Health Insurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China B2B2C Health Insurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China B2B2C Health Insurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan B2B2C Health Insurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan B2B2C Health Insurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan B2B2C Health Insurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea B2B2C Health Insurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea B2B2C Health Insurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea B2B2C Health Insurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India B2B2C Health Insurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India B2B2C Health Insurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India B2B2C Health Insurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia B2B2C Health Insurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia B2B2C Health Insurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia B2B2C Health Insurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia B2B2C Health Insurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia B2B2C Health Insurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia B2B2C Health Insurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil B2B2C Health Insurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil B2B2C Health Insurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil B2B2C Health Insurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina B2B2C Health Insurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina B2B2C Health Insurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina B2B2C Health Insurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile B2B2C Health Insurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile B2B2C Health Insurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile B2B2C Health Insurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia B2B2C Health Insurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia B2B2C Health Insurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia B2B2C Health Insurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru B2B2C Health Insurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru B2B2C Health Insurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru B2B2C Health Insurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia B2B2C Health Insurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia B2B2C Health Insurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia B2B2C Health Insurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel B2B2C Health Insurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel B2B2C Health Insurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel B2B2C Health Insurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE B2B2C Health Insurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE B2B2C Health Insurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE B2B2C Health Insurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey B2B2C Health Insurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey B2B2C Health Insurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey B2B2C Health Insurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran B2B2C Health Insurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran B2B2C Health Insurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran B2B2C Health Insurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt B2B2C Health Insurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt B2B2C Health Insurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt B2B2C Health Insurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Critical Illness Insurance
  • Accident Medical Insurance
  • Disease Management Insurance
  • Other
Applications
  • Individuals
  • Corporates
Companies covered
  • Aditya Birla General Insurance
  • AXA SA
  • Allianz SE
  • Assicurazioni Generali
  • Berkshire Hathaway
  • ICICI Lombard
  • Prudential
  • UnitedHealth Group
  • BNP Paribas
  • Edelweiss General Insurance Company
  • Tata-AIG General Insurance

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global B2B2C Health Insurance Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global B2B2C Health Insurance Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 B2B2C Health Insurance Market Dynamics
  1. 2.1 B2B2C Health Insurance Industry Trends
  2. 2.2 B2B2C Health Insurance Industry Drivers
  3. 2.3 B2B2C Health Insurance Industry Opportunities and Challenges
  4. 2.4 B2B2C Health Insurance Industry Restraints
3 B2B2C Health Insurance Market by Company
  1. 3.1 Global B2B2C Health Insurance Company Revenue Ranking in 2025
  2. 3.2 Global B2B2C Health Insurance Revenue by Company (2021-2026)
  3. 3.3 Global B2B2C Health Insurance Company Ranking (2024-2026)
  4. 3.4 Global B2B2C Health Insurance Company Manufacturing Base and Headquarters
  5. 3.5 Global B2B2C Health Insurance Company Product Type and Application
  6. 3.6 Global B2B2C Health Insurance Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global B2B2C Health Insurance Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 B2B2C Health Insurance Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 B2B2C Health Insurance Market by Type
  1. 4.1 B2B2C Health Insurance Type Introduction
  2. 4.1.1 Critical Illness Insurance
  3. 4.1.2 Accident Medical Insurance
  4. 4.1.3 Disease Management Insurance
  5. 4.1.4 Other
  6. 4.2 Global B2B2C Health Insurance Sales Value by Type
  7. 4.2.1 Global B2B2C Health Insurance Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global B2B2C Health Insurance Sales Value by Type (2021-2032)
  9. 4.2.3 Global B2B2C Health Insurance Sales Value Share by Type (2021-2032)
5 B2B2C Health Insurance Market by Application
  1. 5.1 B2B2C Health Insurance Application Introduction
  2. 5.1.1 Individuals
  3. 5.1.2 Corporates
  4. 5.2 Global B2B2C Health Insurance Sales Value by Application
  5. 5.2.1 Global B2B2C Health Insurance Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global B2B2C Health Insurance Sales Value by Application (2021-2032)
  7. 5.2.3 Global B2B2C Health Insurance Sales Value Share by Application (2021-2032)
6 B2B2C Health Insurance Regional Value Analysis
  1. 6.1 Global B2B2C Health Insurance Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global B2B2C Health Insurance Sales Value by Region (2021-2032)
  3. 6.2.1 Global B2B2C Health Insurance Sales Value by Region: 2021-2026
  4. 6.2.2 Global B2B2C Health Insurance Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America B2B2C Health Insurance Sales Value (2021-2032)
  7. 6.3.2 North America B2B2C Health Insurance Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe B2B2C Health Insurance Sales Value (2021-2032)
  10. 6.4.2 Europe B2B2C Health Insurance Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific B2B2C Health Insurance Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific B2B2C Health Insurance Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America B2B2C Health Insurance Sales Value (2021-2032)
  16. 6.6.2 South America B2B2C Health Insurance Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa B2B2C Health Insurance Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa B2B2C Health Insurance Sales Value Share by Country, 2025 VS 2032
7 B2B2C Health Insurance Country-level Value Analysis
  1. 7.1 Global B2B2C Health Insurance Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global B2B2C Health Insurance Sales Value by Country (2021-2032)
  3. 7.2.1 Global B2B2C Health Insurance Sales Value by Country (2021-2026)
  4. 7.2.2 Global B2B2C Health Insurance Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA B2B2C Health Insurance Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA B2B2C Health Insurance Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA B2B2C Health Insurance Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada B2B2C Health Insurance Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada B2B2C Health Insurance Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada B2B2C Health Insurance Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico B2B2C Health Insurance Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico B2B2C Health Insurance Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico B2B2C Health Insurance Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany B2B2C Health Insurance Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany B2B2C Health Insurance Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany B2B2C Health Insurance Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France B2B2C Health Insurance Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France B2B2C Health Insurance Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France B2B2C Health Insurance Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. B2B2C Health Insurance Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. B2B2C Health Insurance Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. B2B2C Health Insurance Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy B2B2C Health Insurance Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy B2B2C Health Insurance Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy B2B2C Health Insurance Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain B2B2C Health Insurance Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain B2B2C Health Insurance Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain B2B2C Health Insurance Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia B2B2C Health Insurance Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia B2B2C Health Insurance Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia B2B2C Health Insurance Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands B2B2C Health Insurance Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands B2B2C Health Insurance Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands B2B2C Health Insurance Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries B2B2C Health Insurance Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries B2B2C Health Insurance Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries B2B2C Health Insurance Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China B2B2C Health Insurance Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China B2B2C Health Insurance Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China B2B2C Health Insurance Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan B2B2C Health Insurance Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan B2B2C Health Insurance Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan B2B2C Health Insurance Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea B2B2C Health Insurance Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea B2B2C Health Insurance Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea B2B2C Health Insurance Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India B2B2C Health Insurance Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India B2B2C Health Insurance Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India B2B2C Health Insurance Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia B2B2C Health Insurance Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia B2B2C Health Insurance Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia B2B2C Health Insurance Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia B2B2C Health Insurance Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia B2B2C Health Insurance Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia B2B2C Health Insurance Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil B2B2C Health Insurance Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil B2B2C Health Insurance Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil B2B2C Health Insurance Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina B2B2C Health Insurance Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina B2B2C Health Insurance Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina B2B2C Health Insurance Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile B2B2C Health Insurance Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile B2B2C Health Insurance Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile B2B2C Health Insurance Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia B2B2C Health Insurance Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia B2B2C Health Insurance Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia B2B2C Health Insurance Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru B2B2C Health Insurance Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru B2B2C Health Insurance Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru B2B2C Health Insurance Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia B2B2C Health Insurance Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia B2B2C Health Insurance Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia B2B2C Health Insurance Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel B2B2C Health Insurance Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel B2B2C Health Insurance Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel B2B2C Health Insurance Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE B2B2C Health Insurance Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE B2B2C Health Insurance Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE B2B2C Health Insurance Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey B2B2C Health Insurance Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey B2B2C Health Insurance Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey B2B2C Health Insurance Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran B2B2C Health Insurance Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran B2B2C Health Insurance Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran B2B2C Health Insurance Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt B2B2C Health Insurance Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt B2B2C Health Insurance Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt B2B2C Health Insurance Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Aditya Birla General Insurance
  2. 8.1.1 Aditya Birla General Insurance Company Information
  3. 8.1.2 Aditya Birla General Insurance Business Overview
  4. 8.1.3 Aditya Birla General Insurance B2B2C Health Insurance Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Aditya Birla General Insurance B2B2C Health Insurance Product Portfolio
  6. 8.1.5 Aditya Birla General Insurance Recent Developments
  7. 8.2 AXA SA
  8. 8.2.1 AXA SA Company Information
  9. 8.2.2 AXA SA Business Overview
  10. 8.2.3 AXA SA B2B2C Health Insurance Revenue and Gross Margin (2021-2026)
  11. 8.2.4 AXA SA B2B2C Health Insurance Product Portfolio
  12. 8.2.5 AXA SA Recent Developments
  13. 8.3 Allianz SE
  14. 8.3.1 Allianz SE Company Information
  15. 8.3.2 Allianz SE Business Overview
  16. 8.3.3 Allianz SE B2B2C Health Insurance Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Allianz SE B2B2C Health Insurance Product Portfolio
  18. 8.3.5 Allianz SE Recent Developments
  19. 8.4 Assicurazioni Generali
  20. 8.4.1 Assicurazioni Generali Company Information
  21. 8.4.2 Assicurazioni Generali Business Overview
  22. 8.4.3 Assicurazioni Generali B2B2C Health Insurance Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Assicurazioni Generali B2B2C Health Insurance Product Portfolio
  24. 8.4.5 Assicurazioni Generali Recent Developments
  25. 8.5 Berkshire Hathaway
  26. 8.5.1 Berkshire Hathaway Company Information
  27. 8.5.2 Berkshire Hathaway Business Overview
  28. 8.5.3 Berkshire Hathaway B2B2C Health Insurance Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Berkshire Hathaway B2B2C Health Insurance Product Portfolio
  30. 8.5.5 Berkshire Hathaway Recent Developments
  31. 8.6 ICICI Lombard
  32. 8.6.1 ICICI Lombard Company Information
  33. 8.6.2 ICICI Lombard Business Overview
  34. 8.6.3 ICICI Lombard B2B2C Health Insurance Revenue and Gross Margin (2021-2026)
  35. 8.6.4 ICICI Lombard B2B2C Health Insurance Product Portfolio
  36. 8.6.5 ICICI Lombard Recent Developments
  37. 8.7 Prudential
  38. 8.7.1 Prudential Company Information
  39. 8.7.2 Prudential Business Overview
  40. 8.7.3 Prudential B2B2C Health Insurance Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Prudential B2B2C Health Insurance Product Portfolio
  42. 8.7.5 Prudential Recent Developments
  43. 8.8 UnitedHealth Group
  44. 8.8.1 UnitedHealth Group Company Information
  45. 8.8.2 UnitedHealth Group Business Overview
  46. 8.8.3 UnitedHealth Group B2B2C Health Insurance Revenue and Gross Margin (2021-2026)
  47. 8.8.4 UnitedHealth Group B2B2C Health Insurance Product Portfolio
  48. 8.8.5 UnitedHealth Group Recent Developments
  49. 8.9 BNP Paribas
  50. 8.9.1 BNP Paribas Company Information
  51. 8.9.2 BNP Paribas Business Overview
  52. 8.9.3 BNP Paribas B2B2C Health Insurance Revenue and Gross Margin (2021-2026)
  53. 8.9.4 BNP Paribas B2B2C Health Insurance Product Portfolio
  54. 8.9.5 BNP Paribas Recent Developments
  55. 8.10 Edelweiss General Insurance Company
  56. 8.10.1 Edelweiss General Insurance Company Company Information
  57. 8.10.2 Edelweiss General Insurance Company Business Overview
  58. 8.10.3 Edelweiss General Insurance Company B2B2C Health Insurance Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Edelweiss General Insurance Company B2B2C Health Insurance Product Portfolio
  60. 8.10.5 Edelweiss General Insurance Company Recent Developments
  61. 8.11 Tata-AIG General Insurance
  62. 8.11.1 Tata-AIG General Insurance Company Information
  63. 8.11.2 Tata-AIG General Insurance Business Overview
  64. 8.11.3 Tata-AIG General Insurance B2B2C Health Insurance Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Tata-AIG General Insurance B2B2C Health Insurance Product Portfolio
  66. 8.11.5 Tata-AIG General Insurance Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst